Salute e Benessere

Dr. Jonathan Milner Announces Suspension of Proxy Solicitation

Dr. Jonathan Milner Announces Suspension of Proxy SolicitationWill Hold Board Accountable if Strategic Review Fails to Deliver on Company's PromiseCAMBRIDGE, England, 26 June 2023- Dr. Jonathan Milner, the founder and 6.3% shareholder of Abcam PLC (the “Company”), today issued the following statement regarding the upcoming extraordinary meeting of shareholders of the Company:“In light of reports that the Company has received credible inbound M&A interest, and the...
Nasdaq GlobeNewswire
26/06/2023

MoonLake Immunotherapeutics Announces Proposed Underwritten Public Offering

MoonLake ImmunotherapeuticsAnnouncesProposed UnderwrittenPublic OfferingZUG, Switzerland, June 26, 2023 – MoonLake Immunotherapeutics (NASDAQ:MLTX) (“MoonLake”), a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory diseases, today announced that it has commenced an underwritten public offering of $250 million of its Class A ordinary shares and, in lieu of Class A ordinary shares to certain investors that so choose, pre-funded warrants to...
Nasdaq GlobeNewswire
26/06/2023

New ZIRCON Phase III Data Presented at SNMMI: Potential Utility of TLX250-CDx in…

TLX250-CDx PET/CT detected more lesions in liver and bone than diagnostic CT imaging alone. This reinforces the performance of this investigational diagnostic imaging agent across all analyses, with previously presented data showing an excellent overall sensitivity and specificity of 86% and 87%, respectively, together with high intra-reader agreement.[1], [2] TLX250-CDx PET/CT detected more lesions in liver and bone than diagnostic CT imaging alone. This reinforces the performance of this...
PR Newswire
26/06/2023

AB Science receives Notice of Allowance for European patent covering masitinib…

PRESS RELEASEAB SCIENCE RECEIVES NOTICE OF ALLOWANCE FOR EUROPEAN PATENT COVERINGMASITINIB IN THE TREATMENT OF METASTATIC CASTRATE REFRACTORY PROSTATE CANCER (mCRPC) , STRENGTHENING THE COMPANY'S INTELLECTUAL PROPERTY POSITION UNTIL 2042Paris, 26June , 2023 ,6pm CETAB Science SA(Euronext - FR0010557264 - AB) today announced that the European Patent Office has issued a Notice of Allowance for a patent relating to methods of treating...
Nasdaq GlobeNewswire
26/06/2023

miraDry Partners with the International Hyperhidrosis Society to Advance…

This strategic partnership brings together two influential entities in the field of hyperhidrosis, uniting their expertise and resources to address the challenges faced by the more than 365 million individuals worldwide who suffer from the condition1. miraDry's novel technology, known for its effectiveness in treating excessive underarm sweat and odor, complements the IHhS's mission to empower those affected by hyperhidrosis with knowledge, support, and accessible treatment options. This...
PR Newswire
26/06/2023

Sequana Medical announces results of Special General Meeting of Shareholders

PRESS RELEASE REGULATED INFORMATION26 June 2023,06:00 pm CEST Dr . Kenneth Macleod appointed as non-executive director Ghent, Belgium – 26 June 2023– Sequana Medical NV (Euronext Brussels: SEQUA)(the " Company " or " SequanaMedical "), a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, today announces that all proposed resolutions submitted to the Special General...
Nasdaq GlobeNewswire
26/06/2023

Human Serum Albumin (HSA) Market to Exhibit 6.8% CAGR and Generate $7,124.9…

Global Human Serum Albumin (HSA) Market Forecast Analysis: Global Human Serum Albumin (HSA) Market Forecast Analysis: As per the report published by Research Dive, theglobal human serum albumin (HSA) marketis projected to generate a revenue of$7,124.90 millionand grow at a CAGR of 6.8% over the estimated timeframe from 2022 to 2031. Segments of the Human Serum Albumin (HSA) Market The report has divided the human serum albumin (HSA) market into the following segments:...
PR Newswire
26/06/2023

Mithra Announces Information on the Total Number of Voting Rights (Denominator)

MithraAnnounces Information on the Total Number of Voting Rights (Denominator) Liege, Belgium ,26June2023– 17:45 CEST– Mithra (Euronext Brussels: MITRA), a company dedicated to Women's Health, today announces that, following the drawdown of the third tranche by the Company under the loan facility concluded with funds managed by Highbridge Capital Management, LLC (“Highbridge“) and funds managed by Whitebox Advisors, LLC (“Whitebox“, and together...
Nasdaq GlobeNewswire
26/06/2023

New Phase 3 data with aprocitentan for patients with resistant hypertension has…

Allschwil, Switzerland – June 26 , 2023Idorsia Ltd (SIX: IDIA) today announced that further data for aprocitentan, Idorsia's investigational dual endothelin receptor antagonist evaluating the treatment of patients with resistant hypertension, were presented as an oral presentation entitled “Effects of the dual endothelin antagonist aprocitentan on ambulatory blood pressure indices in patients with resistant hypertension – results from the PRECISION study” by Prof. Markus Schlaich,...
Nasdaq GlobeNewswire
26/06/2023

Contract Research Organization Services Market To Touch USD 142.56 Billion…

Get the sample pages of this report: https://www.psmarketresearch.com/market-analysis/cro-services-market/report-sample Get the sample pages of this report:https://www.psmarketresearch.com/market-analysis/cro-services-market/report-sample Clinical research services had the largest share, of over 64%, in 2022. This is because of the growing trial expenses, increasing size of pipeline drugs, rising prevalence of chronic ailments, snowballing trend of outsourcing clinical research, and...
PR Newswire
26/06/2023

Mass Spectrometry Market worth $6.8 billion | MarketsandMarkets

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=437 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=437 Browse in-depth TOC on "Mass Spectrometry Market" 122 - Tables 30 - Figures 188 - Pages Mass Spectrometry Market Scope: Instruments segment to register significant growth rate over the forecast period of 2023-2028 Based on the product, the mass spectrometry is segmented...
PR Newswire
26/06/2023

Global Mobile Health Vehicle Market to Surpass USD 393 Mn By 2031| Growth Market…

Download PDF Sample here: ��https://growthmarketreports.com/request-sample/5317 Download PDF Sample here: ��https://growthmarketreports.com/request-sample/5317 The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics. It provides an in-depth analysis of the market segments, which include product, application, and competitor analysis. This report also includes a complete analysis of industry...
PR Newswire
26/06/2023

Sobi completes acquisition of CTI BioPharma Corp.

At the effective time of the merger, and subject to any perfected appraisal rights, all of the remaining shares of common stock of CTI not purchased in the tender offer were converted into the right to receive the same USD 9.10 per share, net to the seller thereof in cash, without interest and subject to any applicable withholding taxes. The transaction is valued at up to USD 1.7 billion (approximately SEK 17.1 billion) on a fully diluted basis. At the effective time of the merger, and…
PR Newswire
26/06/2023

Global Clinical Research Organization (CRO) Market to Reach USD 220.3 Billion By…

In November 2022, one of the market players from the United States, IQVIA, came into partnership with an Israeli company, Clalit Health Services, to combine their genomic research, data, and clinical trial delivery. This collaboration is expected to transform pharmaceutical research and healthcare infrastructure for Israel as well as the world. InNovember 2022,one of the market players fromthe United States, IQVIA, came into partnership with an Israeli company, Clalit Health Services,...
PR Newswire
26/06/2023

10 Billion Reason to Believe in Hygiene: Global disinfectant Market on the Rise…

According to Ken Research estimates, the Global Surface Disinfectant Market – which reached ~US$ 6 Bn in 2022 – is expected to reach ~US$ 10 Bn opportunity by 2028. Ken Research shares 5 key insights on this high-opportunity Global Surface Disinfectant market from its latest research study. According to Ken Researchestimates, the Global Surface Disinfectant Market – which reached~US$ 6 Bnin 2022 – is expected to reach~US$ 10 Bnopportunity by 2028. Ken Research shares 5 key...
PR Newswire
26/06/2023

HitGen launches a newly upgraded version of OpenDEL™, a self-service screening…

OpenDEL™ is a fully-open, transparent, small molecule screening kit, featuring complete disclosure of information for molecular structures, building blocks, scaffolds and compound encoding sequences. The users do not need to pay structure disclosure fees, nor compound IP license fees. OpenDEL™ is a fully-open, transparent, small molecule screening kit, featuring complete disclosure of information for molecular structures, building blocks, scaffolds and compound encoding sequences. The users…
PR Newswire
26/06/2023

Endo Announces First Patient Enrolled in Registry of Dupuytren's Contracture

"We're pleased to support this unprecedented effort to help advance understanding and treatment of Dupuytren's contracture," said Gregory Kaufman, M.D., Vice President, Medical Affairs and Chief Medical Officer at Endo. "Along with our study steering committee partners, Endo is committed to supporting the Dupuytren's patient community." "We're pleased to support this unprecedented effort to help advance understanding and treatment of Dupuytren's contracture,"…
PR Newswire
26/06/2023

Novo Nordisk A/S - share repurchase programme

Bagsværd , Denmark, 26June 2023– On 9 May 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 30 billion to be executed during a 12-month period beginning 1 February 2023. Under the...
Nasdaq GlobeNewswire
26/06/2023

uniQure Announces Leadership Addition to Support Advancement of Clinical…

~ Walid Abi-Saab, M.D., appointed Chief Medical Officer, will bring extensive track record in leading drug development and execution ~ uniQureN.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced the appointment of Walid Abi-Saab, M.D., as Chief Medical Officer, effective immediately. He will report toMatt Kapusta, Chief Executive Officerof uniQure, and will be based in the Company's Basel,...
Nasdaq GlobeNewswire
26/06/2023

Recently-Appointed Independent Directors of Alkermes Issue Open Letter to…

The Board recommends that shareholders vote 'FOR' Emily Peterson Alva, Shane M. Cooke, Richard B. Gaynor, M.D., Cato T. Laurencin, M.D., Ph.D., Brian P. McKeon, Richard F. Pops and Christopher I. Wright, M.D., Ph.D. using the WHITE proxy card. The Board recommends that shareholders vote 'FOR'Emily Peterson Alva,Shane M. Cooke,Richard B. Gaynor, M.D.,Cato T. Laurencin, M.D., Ph.D.,Brian P. McKeon, Richard F. Pops andChristopher I. Wright, M.D., Ph.D. using the WHITE proxy...
PR Newswire
26/06/2023

PanTera and TerraPower Isotopes join forces to accelerate access to actinium-225

Strategic collaboration signed to supportthe development of radiopharmaceuticals in the fight against cancerChicago, IL, USA, June 26, 2023:TerraPower Isotopes and PanTera, the Belgian joint venture created by SCK CEN and IBA , announced today that they have signed a strategic collaboration to increase the global availability of actinium-225 ( 225 Ac), a radioisotope that has the potential to treat a large variety of cancer indications. The companies will work together to...
Nasdaq GlobeNewswire
26/06/2023

Medical Billing Outsourcing Market to be Worth $30.2 Billion by 2030: Grand View…

Read full market research report, "Medical Billing Outsourcing Market Size, Share & Trends Analysis Report By Component (In-house, Outsourced), By Service (Front-End, Middle-End, Back-End), By End-use, By Region, And Segment Forecasts, 2023 - 2030", published by Grand View Research. Read full market research report, " Medical Billing Outsourcing Market Size, Share & Trends Analysis Report By Component (In-house, Outsourced), By Service (Front-End, Middle-End, Back-End), By…
PR Newswire
26/06/2023

Fairtility Unveils CHLOE OQ™ Expanding its Offering into Fertility Preservation

With CE declared for CHLOE OQ™, the new Oocyte Quality Insights capability offers IVF professionals comprehensive information to support decision making as patients undergo fertility preservation or assisted reproductive journeys. CHLOE OQ delivers predictions of an oocyte's potential to reach the blastocyst stage post-fertilization. With CE declared for CHLOE OQ™, the new Oocyte Quality Insights capability offers IVF professionals comprehensive information to support decision making as...
PR Newswire
26/06/2023

Reacta Healthcare appoints Kevin Hawkins as Head of Regulatory Affairs

"We are delighted to welcome Kevin to the Reacta Senior Leadership Team at this critical juncture in the company's development. Kevin is a highly skilled and respected senior leader with a strong track record in R&D and Regulatory Affairs. His experience in dealing with regulators and his practical approach to regulatory matters will be a great asset to Reacta and will be invaluable in contributing to the growth of the company," Dr. Paul Abrahams, CEO said. "We are delighted…
PR Newswire
26/06/2023
Altri  Comunicati